NIH Launches Clinical Trial to Study Hydroxychloroquine Efficacy in COVID-19,

The NIAID is sponsoring a large clinical trial to evaluate whether hydroxychloroquine, given with azithromycin, can improve clinical outcomes from COVID-19., The NIAID is sponsoring a large clinical trial to evaluate whether hydroxychloroquine, given with azithromycin, can improve clinical outcomes from COVID-19., Read More

Scroll to Top